NYSE:KND - Kindred Healthcare Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$9.00 -0.05 (-0.55 %)
(As of 06/25/2018 02:12 AM ET)
Previous Close$9.00
Today's Range$8.95 - $9.05
52-Week Range$5.50 - $11.90
Volume2.51 million shs
Average Volume473,764 shs
Market Capitalization$825.91 million
P/E Ratio26.47
Dividend YieldN/A
Beta1.05
Kindred Healthcare logoKindred Healthcare, Inc. provides healthcare services in the United States. It operates through five segments: Home Health Services, Hospice Services, Hospitals, Kindred Hospital Rehabilitation Services, and RehabCare. The company provides long-term acute care (LTAC) services to post-intensive care and medically complex patients, including the critically ill and suffering from multiple organ system failures most commonly of the cardiovascular, pulmonary, kidney, gastro-intestinal, and cutaneous systems. It also offers home health, hospice, and community care services for patients in various settings comprising their homes, nursing centers, and other residential settings, as well as physician services for patients in home-based settings. In addition, the company operates inpatient rehabilitation hospitals (IRFs) and acute rehabilitation units (ARUs); and provides rehabilitation services, including physical and occupational therapies and speech pathology services to residents and patients of nursing centers, hospitals, outpatient clinics, home health agencies, and assisted living facilities. As of December 31, 2017, it operated 19 IRFs, 99 ARUs, 104 LTAC hospitals, 4 sub-acute units, and 123 outpatient clinics; provided rehabilitative services from 1,616 sites of service in 42 states; and offered Kindred at Home division home health, hospice, and community care services from 608 sites of service in 40 states. The company is headquartered in Louisville, Kentucky.

Receive KND News and Ratings via Email

Sign-up to receive the latest news and ratings for KND and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Nursing & personal care facilities
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolNYSE:KND
CUSIP49458010
Phone502-596-7300

Debt

Debt-to-Equity Ratio10.04
Current Ratio1.73
Quick Ratio1.70

Price-To-Earnings

Trailing P/E Ratio26.47
Forward P/E Ratio14.06
P/E GrowthN/A

Sales & Book Value

Annual Sales$6.03 billion
Price / Sales0.14
Cash Flow$1.6129 per share
Price / Cash5.58
Book Value$3.80 per share
Price / Book2.37

Profitability

EPS (Most Recent Fiscal Year)$0.34
Net Income$-698,350,000.00
Net Margins-11.56%
Return on Equity11.38%
Return on Assets0.93%

Miscellaneous

Employees85,300
Outstanding Shares91,260,000

The Truth About Cryptocurrencies

Kindred Healthcare (NYSE:KND) Frequently Asked Questions

What is Kindred Healthcare's stock symbol?

Kindred Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "KND."

How were Kindred Healthcare's earnings last quarter?

Kindred Healthcare, Inc. (NYSE:KND) announced its quarterly earnings data on Wednesday, February, 28th. The health services provider reported $0.20 EPS for the quarter, beating the Zacks' consensus estimate of $0.18 by $0.02. The health services provider earned $1.48 billion during the quarter, compared to analyst estimates of $1.48 billion. Kindred Healthcare had a negative net margin of 11.56% and a positive return on equity of 11.38%. The firm's revenue for the quarter was down 2.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.05 earnings per share. View Kindred Healthcare's Earnings History.

What price target have analysts set for KND?

5 analysts have issued 1-year target prices for Kindred Healthcare's shares. Their forecasts range from $6.50 to $9.00. On average, they anticipate Kindred Healthcare's share price to reach $8.00 in the next year. View Analyst Ratings for Kindred Healthcare.

Who are some of Kindred Healthcare's key competitors?

Who are Kindred Healthcare's key executives?

Kindred Healthcare's management team includes the folowing people:
  • Mr. Benjamin A. Breier, Pres, CEO & Director (Age 46)
  • Mr. Stephen D. Farber, Exec. VP & CFO (Age 48)
  • Mr. Kent H. Wallace, Exec. VP & COO (Age 63)
  • Mr. Stephen R. Cunanan, Chief Admin. Officer & Chief People Officer (Age 54)
  • Mr. David A. Causby, Exec. VP & Pres of Kindred at Home (Age 46)

Has Kindred Healthcare been receiving favorable news coverage?

Headlines about KND stock have been trending somewhat positive on Monday, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Kindred Healthcare earned a media sentiment score of 0.22 on Accern's scale. They also assigned media headlines about the health services provider an impact score of 47.45 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Kindred Healthcare's major shareholders?

Kindred Healthcare's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.94%), Dimensional Fund Advisors LP (5.70%), JPMorgan Chase & Co. (5.39%), Water Island Capital LLC (3.37%), UBS Group AG (2.81%) and JPMORGAN CHASE & COMPANY (2.40%). View Institutional Ownership Trends for Kindred Healthcare.

Which institutional investors are selling Kindred Healthcare stock?

KND stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., South Dakota Investment Council, California Public Employees Retirement System, Thrivent Financial for Lutherans, OppenheimerFunds Inc., KBC Group NV, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp and Legal & General Group Plc. View Insider Buying and Selling for Kindred Healthcare.

Which institutional investors are buying Kindred Healthcare stock?

KND stock was bought by a variety of institutional investors in the last quarter, including Water Island Capital LLC, UBS Group AG, SG Americas Securities LLC, Citigroup Inc., BlackRock Inc., Prosight Management LP, GABELLI & Co INVESTMENT ADVISERS INC. and Hsbc Holdings PLC. View Insider Buying and Selling for Kindred Healthcare.

How do I buy shares of Kindred Healthcare?

Shares of KND can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Kindred Healthcare's stock price today?

One share of KND stock can currently be purchased for approximately $9.00.

How big of a company is Kindred Healthcare?

Kindred Healthcare has a market capitalization of $825.91 million and generates $6.03 billion in revenue each year. The health services provider earns $-698,350,000.00 in net income (profit) each year or $0.34 on an earnings per share basis. Kindred Healthcare employs 85,300 workers across the globe.

How can I contact Kindred Healthcare?

Kindred Healthcare's mailing address is 680 South Fourth Street, Louisville KY, 40202. The health services provider can be reached via phone at 502-596-7300 or via email at [email protected]


MarketBeat Community Rating for Kindred Healthcare (KND)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  204 (Vote Outperform)
Underperform Votes:  283 (Vote Underperform)
Total Votes:  487
MarketBeat's community ratings are surveys of what our community members think about Kindred Healthcare and other stocks. Vote "Outperform" if you believe KND will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KND will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.